Anti-CREG2 functional antibody

Anti-CREG2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CREG2/CREG2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0819-Ab-1/ GM-Tg-hg-SE0819-Ab-2Anti-Human CREG2 monoclonal antibodyHuman
GM-Tg-rg-SE0819-Ab-1/ GM-Tg-rg-SE0819-Ab-2Anti-Rat CREG2 monoclonal antibodyRat
GM-Tg-mg-SE0819-Ab-1/ GM-Tg-mg-SE0819-Ab-2Anti-Mouse CREG2 monoclonal antibodyMouse
GM-Tg-cynog-SE0819-Ab-1/ GM-Tg-cynog-SE0819-Ab-2Anti-Cynomolgus/ Rhesus macaque CREG2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0819-Ab-1/ GM-Tg-felg-SE0819-Ab-2Anti-Feline CREG2 monoclonal antibodyFeline
GM-Tg-cang-SE0819-Ab-1/ GM-Tg-cang-SE0819-Ab-2Anti-Canine CREG2 monoclonal antibodyCanine
GM-Tg-bovg-SE0819-Ab-1/ GM-Tg-bovg-SE0819-Ab-2Anti-Bovine CREG2 monoclonal antibodyBovine
GM-Tg-equg-SE0819-Ab-1/ GM-Tg-equg-SE0819-Ab-2Anti-Equine CREG2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0819-Ab-1/ GM-Tg-hg-SE0819-Ab-2; GM-Tg-rg-SE0819-Ab-1/ GM-Tg-rg-SE0819-Ab-2;
GM-Tg-mg-SE0819-Ab-1/ GM-Tg-mg-SE0819-Ab-2; GM-Tg-cynog-SE0819-Ab-1/ GM-Tg-cynog-SE0819-Ab-2;
GM-Tg-felg-SE0819-Ab-1/ GM-Tg-felg-SE0819-Ab-2; GM-Tg-cang-SE0819-Ab-1/ GM-Tg-cang-SE0819-Ab-2;
GM-Tg-bovg-SE0819-Ab-1/ GM-Tg-bovg-SE0819-Ab-2; GM-Tg-equg-SE0819-Ab-1/ GM-Tg-equg-SE0819-Ab-2
Products NameAnti-CREG2 monoclonal antibody
Formatmab
Target NameCREG2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CREG2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0819-Ag-1Recombinant multi-species CREG2 protein


    Target information

    Target IDGM-SE0819
    Target NameCREG2
    Gene ID200407,263764,316353,711082,611525,101085364,618618,100059003
    Gene Symbol and SynonymsA830098L22Rik,CREG2,Creg2-ps1,RGD1564056
    Uniprot AccessionQ8IUH2
    Uniprot Entry NameCREG2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000175874
    Target ClassificationN/A

    The target: CREG2, gene name: CREG2, also named as . Predicted to be located in Golgi apparatus and endoplasmic reticulum. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.